Barry E. Greene - 02 Jun 2021 Form 4 Insider Report for ACORDA THERAPEUTICS INC

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 02 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2021, 07:11:27 UTC
Prior SEC filing: 21 May 2021
Next SEC filing: 17 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ Barry E. Greene

Key filing fact

Barry E. Greene filed Form 4 for ACORDA THERAPEUTICS INC on 04 Jun 2021.

Key facts

This page summarizes Barry E. Greene's Form 4 filing for ACORDA THERAPEUTICS INC.
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 04 Jun 2021, 07:11.

Change

Previous filing in this sequence was filed on 21 May 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ACOR transaction Derivative

Non-Employee Stock Option

Award

Transaction value: $0
Shares: +10,000
Change %
Price: $0.000000
Shares after: 10,000
Date: 02 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $3.75
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to this option vest in four equal quarterly installments over 12 months beginning on June 2, 2021, with the first quarterly installment vesting on September 2, 2021.